FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100476032> ?p ?o ?g. }

• W2100476032 endingPage "977" @default.
• W2100476032 startingPage "973" @default.
• W2100476032 abstract "To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland) (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria, we conducted a comparative clinical trial of these 3 drugs in an open-label study. Patients (15-65 years old) were assigned to 1 of 4 treatments regimens in a serial order. Ninety percent of the patients were infected at Thailand-Myanmar border. Patients in group I (n = 23) received Fansidar (3 tablets, 75 mg of pyrimethamine and 1,500 mg of sulfadoxine, a single dose on the first day), group II (n = 23) received Fansidar (3 tablets, 75 mg of pyrimethamine and 1,500 mg of sulfadoxine, a single dose on the first day) and then received primaquine (30 mg a day for 14 days), group III (n = 23) received primaquine (30 mg a day for 14 days), and group IV (n = 23) received artesunate (200 mg once a day for 3 days) and then primaquine (30 mg a day for 14 days). Cure rates on day 28 of follow-up were 40%, 100%, 100%, and 100% in groups I, II, II, and IV, respectively. There were 4 and 5 patients in group I showing post-treatment reappearance of parasitemia at < or = 16 days and between 17 and 28 days, respectively. Patients in the other 3 groups showed negative parasitemias within 7 days after treatment. Artesunate plus primaquine (group IV) cleared parasitemia faster than the other 3 regimens. There is a high proportion of ineffectiveness of Fansidar for treatment of P. vivax malaria and it should be no longer used for treatment of P. vivax malaria acquired at the Thailand-Myanmar border. A high dose of primaquine is safe and effective in the treatment of P. vivax malaria during the 28-day follow-up period." @default.
• W2100476032 created "2016-06-24" @default.
• W2100476032 creator A5001027718 @default.
• W2100476032 creator A5001568283 @default.
• W2100476032 creator A5018510690 @default.
• W2100476032 creator A5027391063 @default.
• W2100476032 creator A5030457983 @default.
• W2100476032 creator A5050635198 @default.
• W2100476032 creator A5060343662 @default.
• W2100476032 creator A5084357280 @default.
• W2100476032 creator A5089194097 @default.
• W2100476032 date "1999-12-01" @default.
• W2100476032 modified "2023-09-24" @default.
• W2100476032 title "Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand." @default.
• W2100476032 cites W1967390083 @default.
• W2100476032 cites W1974913629 @default.
• W2100476032 cites W1979437702 @default.
• W2100476032 cites W2005109719 @default.
• W2100476032 cites W2007154151 @default.
• W2100476032 cites W2034954401 @default.
• W2100476032 cites W2047106428 @default.
• W2100476032 cites W2063074123 @default.
• W2100476032 cites W2076030070 @default.
• W2100476032 cites W2121405778 @default.
• W2100476032 cites W2125089473 @default.
• W2100476032 cites W2168670624 @default.
• W2100476032 cites W2401730911 @default.
• W2100476032 cites W2402672654 @default.
• W2100476032 cites W2414983031 @default.
• W2100476032 cites W2416037978 @default.
• W2100476032 cites W2465252452 @default.
• W2100476032 doi "https://doi.org/10.4269/ajtmh.1999.61.973" @default.
• W2100476032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10674681" @default.
• W2100476032 hasPublicationYear "1999" @default.
• W2100476032 type Work @default.
• W2100476032 sameAs 2100476032 @default.
• W2100476032 citedByCount "48" @default.
• W2100476032 countsByYear W21004760322012 @default.
• W2100476032 countsByYear W21004760322013 @default.
• W2100476032 countsByYear W21004760322014 @default.
• W2100476032 countsByYear W21004760322015 @default.
• W2100476032 countsByYear W21004760322016 @default.
• W2100476032 countsByYear W21004760322017 @default.
• W2100476032 countsByYear W21004760322021 @default.
• W2100476032 countsByYear W21004760322023 @default.
• W2100476032 crossrefType "journal-article" @default.
• W2100476032 hasAuthorship W2100476032A5001027718 @default.
• W2100476032 hasAuthorship W2100476032A5001568283 @default.
• W2100476032 hasAuthorship W2100476032A5018510690 @default.
• W2100476032 hasAuthorship W2100476032A5027391063 @default.
• W2100476032 hasAuthorship W2100476032A5030457983 @default.
• W2100476032 hasAuthorship W2100476032A5050635198 @default.
• W2100476032 hasAuthorship W2100476032A5060343662 @default.
• W2100476032 hasAuthorship W2100476032A5084357280 @default.
• W2100476032 hasAuthorship W2100476032A5089194097 @default.
• W2100476032 hasBestOaLocation W21004760321 @default.
• W2100476032 hasConcept C126322002 @default.
• W2100476032 hasConcept C203014093 @default.
• W2100476032 hasConcept C2775867548 @default.
• W2100476032 hasConcept C2776793103 @default.
• W2100476032 hasConcept C2777035104 @default.
• W2100476032 hasConcept C2777425658 @default.
• W2100476032 hasConcept C2778048844 @default.
• W2100476032 hasConcept C2778059366 @default.
• W2100476032 hasConcept C2778301690 @default.
• W2100476032 hasConcept C2778371730 @default.
• W2100476032 hasConcept C2779997623 @default.
• W2100476032 hasConcept C71924100 @default.
• W2100476032 hasConcept C98274493 @default.
• W2100476032 hasConceptScore W2100476032C126322002 @default.
• W2100476032 hasConceptScore W2100476032C203014093 @default.
• W2100476032 hasConceptScore W2100476032C2775867548 @default.
• W2100476032 hasConceptScore W2100476032C2776793103 @default.
• W2100476032 hasConceptScore W2100476032C2777035104 @default.
• W2100476032 hasConceptScore W2100476032C2777425658 @default.
• W2100476032 hasConceptScore W2100476032C2778048844 @default.
• W2100476032 hasConceptScore W2100476032C2778059366 @default.
• W2100476032 hasConceptScore W2100476032C2778301690 @default.
• W2100476032 hasConceptScore W2100476032C2778371730 @default.
• W2100476032 hasConceptScore W2100476032C2779997623 @default.
• W2100476032 hasConceptScore W2100476032C71924100 @default.
• W2100476032 hasConceptScore W2100476032C98274493 @default.
• W2100476032 hasIssue "6" @default.
• W2100476032 hasLocation W21004760321 @default.
• W2100476032 hasLocation W21004760322 @default.
• W2100476032 hasOpenAccess W2100476032 @default.
• W2100476032 hasPrimaryLocation W21004760321 @default.
• W2100476032 hasRelatedWork W2013263702 @default.
• W2100476032 hasRelatedWork W2028082124 @default.
• W2100476032 hasRelatedWork W2100476032 @default.
• W2100476032 hasRelatedWork W2166247446 @default.
• W2100476032 hasRelatedWork W2242093551 @default.
• W2100476032 hasRelatedWork W2329436567 @default.
• W2100476032 hasRelatedWork W2336832184 @default.
• W2100476032 hasRelatedWork W2357740749 @default.
• W2100476032 hasRelatedWork W4289765013 @default.
• W2100476032 hasRelatedWork W83284349 @default.
• W2100476032 hasVolume "61" @default.

• next